Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?

Abstract Background [18F] fluorodeoxyglucose positron emission tomography/computed tomography ([18F] FDG-PET/CT) may be used for tumor staging and prognosis in several tumors but its role in rectal cancer is still debated. The aim of the present study was to assess the correlation of baseline [18F]...

Full description

Bibliographic Details
Main Authors: Letizia Deantonio, Angela Caroli, Erinda Puta, Daniela Ferrante, Francesco Apicella, Lucia Turri, Gianmauro Sacchetti, Marco Brambilla, Marco Krengli
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Radiation Oncology
Subjects:
Rectal cancer
[18F] fluorodeoxyglucose positron emission tomography
Standardized uptake value
Metabolic tumor volume
Total lesion glycolysis
Predictive value
Online Access:http://link.springer.com/article/10.1186/s13014-018-1154-3

Internet

http://link.springer.com/article/10.1186/s13014-018-1154-3

Similar Items